Peroxisome proliferator-activator receptor gamma ligands reduce cancer cell division by repressing NHE1 expression [80], while xenograft models demonstrate that deficient NHE1 activity or NHE1 deletion inhibits tumour growth [86, 87]. Here, SLC9A1 is linked to cancer.